Lotronex and the FDA: a fatal erosion of integrity
- 1 May 2001
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 357 (9268) , 1544-1545
- https://doi.org/10.1016/s0140-6736(00)04776-0
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Irritable Bowel SyndromeDrugs, 2001
- Alosetron in irritable bowel syndromeThe Lancet, 2000
- Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trialThe Lancet, 2000